In comparison with adjacent noncancerous tissues, the mRNA expression levels of MYBL2 were increased both in colorectal adenomas and all stages of CRC in the TCGA and GEO cohorts (Figs. 1E, 1F). The gene discussed is MYBL2; the disease is colorectal adenoma.